HER2 positive rates are enriched amongst colorectal cancer brain metastases: a study amongst 1920 consecutive patients

Ann Oncol. 2018 Jul 1;29(7):1598-1599. doi: 10.1093/annonc/mdy156.

Authors

R Y C Tan¹, M D Camat¹, M Ng¹, T H Lim², A S T Lim², K H Lim², I B H Tan³

Affiliations

¹ Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
² Department of Pathology, Singapore General Hospital, Singapore, Singapore.
³ Division of Medical Oncology, National Cancer Centre Singapore, Singapore. Electronic address: [email protected].

PMID: 29868843
DOI: 10.1093/annonc/mdy156

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor / metabolism*
Brain Neoplasms / metabolism
Brain Neoplasms / secondary*
Colorectal Neoplasms / metabolism
Colorectal Neoplasms / pathology*
Humans
Prognosis
Receptor, ErbB-2 / metabolism*

Substances

Biomarkers, Tumor
ERBB2 protein, human
Receptor, ErbB-2